Cargando…
SIRT1: A Potential Therapeutic Target in Autoimmune Diseases
The morbidity and mortality of autoimmune diseases (Ads) have been increasing worldwide, and the identification of novel therapeutic strategies for prevention and treatment is urgently needed. Sirtuin 1 (SIRT1), a member of the class III family of nicotinamide adenine dinucleotide (NAD(+))-dependent...
Autores principales: | Shen, Pan, Deng, Xuan, Chen, Zhe, Ba, Xin, Qin, Kai, Huang, Ying, Huang, Yao, Li, Tingting, Yan, Jiahui, Tu, Shenghao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650132/ https://www.ncbi.nlm.nih.gov/pubmed/34887866 http://dx.doi.org/10.3389/fimmu.2021.779177 |
Ejemplares similares
-
Potential Implications of Quercetin in Autoimmune Diseases
por: Shen, Pan, et al.
Publicado: (2021) -
Multifaceted oncostatin M: novel roles and therapeutic potential of the oncostatin M signaling in rheumatoid arthritis
por: Han, Liang, et al.
Publicado: (2023) -
T peripheral helper cells in autoimmune diseases: What do we know?
por: Huang, Yao, et al.
Publicado: (2023) -
Dyslipidemia in rheumatoid arthritis: the possible mechanisms
por: Yan, Jiahui, et al.
Publicado: (2023) -
Interleukin 27 Signaling in Rheumatoid Arthritis Patients: Good or Evil?
por: Han, Liang, et al.
Publicado: (2022)